The Era of Human Data is Here
Revalia’s platform enables Human Data Trials—accelerating drug development with real human data, before the first clinical trial begins.
Without Revalia
Incomplete data, over-reliance on animal models and institutional barriers have held back drug discovery and development for too long.
Based on in silico or animal-derived targets with no human correlation
Slow animal-based models, poor translatability
Late surprises, poor stratification, trial redesigns
Limited, human-relevant data to support claims
Unexpected responses in real-world settings
With Revalia
Revalia changes the game with a revolutionary human data infrastructure solution, designed from the ground up for biopharma leaders and their inter-institutional collaborators.
Access to human tissues enables better target validation from the start
Human Data Trials reveal mechanisms and risk early
Early human insights inform design, biomarkers and dosing strategies
Mechanistic evidence from human tissues de-risks filings
Human data improves confidence in real-world translatability
How we do it
Revalia is the first and only platform that integrates every layer of the human data stack
Introducing Human Data Trials
A new chapter in translational research.
The traditional research pipeline waits too long for human relevance. Human Data Trials offer an earlier window into biology—before patient risk and clinical trial expense.
Honoring the gift: The transformative potential of transplant-declined human organs →
American Journal of Transplantation, Volume 23, Issue 2, 165 - 170
Data are the connective tissue
Pharma
Revalia accelerates drug development by delivering high-fidelity, organ-based human data before clinical trials begin. Gain earlier insights into safety, efficacy, and mechanism of action—reducing downstream failure and R&D waste.
Health systems, physicians, scientists
Revalia enables physician-scientists to generate publication-grade insights using donated, perfused human organs. Build institutional leadership in translational science while accelerating discovery beyond the limits of traditional animal models.
Biotech
Revalia provides early, clinically relevant human data that helps biopharma teams evaluate therapeutic candidates faster, reduce trial risk, and identify the most promising paths forward before entering costly trials.
Organ donors
Revalia turns the gift of organ donation into a powerful engine for discovery. Each donation supports dozens of studies that advance medicine, improve patient care, and bring dignity and purpose to the donor’s legacy.
“I've been chasing this type of opportunity for ~8 years. The challenge has been the infrastructure to facilitate research donor organs paired with having the folks skilled to perform the experiments on short notice.
The team at Revalia has addressed these challenges and have opened the door for some incredible research opportunities.”
